Agenda Items

The Board will consider and approve the following matters:

  • Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026
  • Proposal for variation in the objects of the Rights Issue, as disclosed in the Letter of Offer dated April 19, 2025, subject to approval of shareholders by way of a Special Resolution
  • Proposal for increase in the ESOP Pool under the Company's Employee Stock Option Scheme, 2021, as approved by the Nomination and Remuneration Committee (Designated Committee), subject to such approvals as may be required
  • Any other business with the permission of the Chair

Trading Window Closure

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Insider Trading - Code of Conduct, the Trading Window for designated persons (and their relatives) remains closed from 1st July, 2026 and will remain closed until 48 hours after the declaration of the financial results made on 6th August, 2026 becomes generally available to the public.